A Surgical Sale: Biotech Executives and the Art of Timing

Harpreet S. Dhaliwal, Chief Technical Ops Officer of Vaxcyte (PCVX +0.69%), recently orchestrated a transaction worthy of a stock market ballet-disposing of 9,743 shares in a maneuver that netted approximately $454,891, as documented in the sacred scrolls of SEC Form 4.




